Peijia Medical-B (09996.HK): Edwards Lifesciences plans to acquire JenaValve through a merger.
On July 26th, Guolong News reported that Peijia Medical-B (09996.HK) announced that its wholly-owned subsidiary, Marvel Finder Limited, holds about 1.91% (calculated on a fully diluted and conversion basis) of JenaValve's minority equity, which is recorded in the company's comprehensive financial statements as a financial asset measured at fair value. JenaValve has notified the company that on July 23, 2024 (US time), Edwards Lifesciences (through its wholly-owned subsidiary) agreed to acquire the shares.
Heard on the Street Recap: Detroit Blues -- WSJ
Edwards Lifesciences (NYSE:EW) Plunges 31% After J.P. Morgan and Truist Downgrades
Corporate Earnings, GDP Data Leave Equity Markets Mixed
Nvidia, Alphabet, Microsoft, Drag S&P, Nasdaq Lower | Wall Street Today
Edwards Lifesciences Options Spot-On: On July 25th, 158.3K Contracts Were Traded, With 74,578 Open Interest
Edwards Lifesciences Stock Plummeted Today. Here's Why
US Equities Markets End Mixed Thursday as Markets Parse Economic Data, Quarterly Results
Edwards Lifesciences Cut to Hold From Buy by TD Cowen
Edwards Lifesciences Price Target Cut to $70.00/Share From $100.00 by TD Cowen
Top Midday Decliners
Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Industrials, Energy Push US Equity Indexes Higher Ahead of Fed's Preferred Inflation Print
These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results
Edwards Lifesciences Shares Tumble After Downgrades, Price Target Cuts Following Q2 Results
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
Edwards Lifesciences Downgraded at JPM, Truist on Slower Transcatheter Valve Growth